John Schaetzl

Voorzitter bij

Stichting Access To Medicine Foundation

Consumer Services

Finance

Health Technology

Profiel

John Schaetzl is currently the Chairman-Supervisory Board at Stichting Access To Medicine Foundation.
Previously, he worked as a Research Vice President at GE Asset Management, Inc. from 1998 to 2008.
He also worked as a Principal at Miles Laboratories, Inc. Mr. Schaetzl received his undergraduate degree from Harvard University and his graduate degree from the University of Pennsylvania.

Actieve functies van John Schaetzl

Bedrijven	Functie	Begin
Stichting Access To Medicine Foundation Stichting Access To Medicine Foundation Miscellaneous Commercial ServicesCommercial Services Engages in stimulating and guiding pharmaceutical companies to do more for the people living in low- and middle-income countries without access to medicine	Voorzitter	-

Alle actieve functies van John Schaetzl

Eerdere bekende functies van John Schaetzl

Bedrijven	Functie	Einde
GE Asset Management, Inc. GE Asset Management, Inc. Investment ManagersFinance GE Asset Management's (GEAM) core investment strategies include US equities, international equities, fixed-income, real estate and private equity. The firm follows a disciplined, fundamental, bottom-up approach to investing in US equities. Their US equity investment approach involves rigorous analyses of financial data, including industry, sector and company information, as well as qualitative assessments of management and their ability to execute business plans. Generally, GEAM invests in companies that are industry leaders with high quality earnings and a history of creating shareholder value. GEAM's international equities approach includes a variety of strategies such as International Equity, Global Equity and Emerging Markets Equity, as well as regional and country specific mandates for Canada, Europe, Euroland, China and India. All strategies are driven by a bottom-up, fundamental research process. GEAM's fixed-income team manages a variety of investment styles and strategies that span the yield curve and credit quality universe. The firm manages a variety of products designed to meet various customer risk/return parameters. GEAM's fixed-income team follows a relative value approach, emphasizing a fundamental, bottom-up process with the objective of enhancing returns while limiting volatility. The firm's International Private Equity team invests in companies domiciled and doing a substantial portion of their business outside of the US. They focus primarily on corporate buyouts and growth-equity investments, but they also selectively consider later-stage venture capital investments. GEAM considers investment opportunities across a broad range of industrial sectors and geographic areas and pursues potential investment opportunities in both developed and emerging markets.	Analyst-Equity	31-10-2008
Miles Laboratories, Inc. Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Verkoop & Marketing	31-12-1997

Ervaring van John Schaetzl in detail bekijken

Opleiding van John Schaetzl

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van John Schaetzl in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	5
GE Asset Management, Inc. GE Asset Management, Inc. Investment ManagersFinance GE Asset Management's (GEAM) core investment strategies include US equities, international equities, fixed-income, real estate and private equity. The firm follows a disciplined, fundamental, bottom-up approach to investing in US equities. Their US equity investment approach involves rigorous analyses of financial data, including industry, sector and company information, as well as qualitative assessments of management and their ability to execute business plans. Generally, GEAM invests in companies that are industry leaders with high quality earnings and a history of creating shareholder value. GEAM's international equities approach includes a variety of strategies such as International Equity, Global Equity and Emerging Markets Equity, as well as regional and country specific mandates for Canada, Europe, Euroland, China and India. All strategies are driven by a bottom-up, fundamental research process. GEAM's fixed-income team manages a variety of investment styles and strategies that span the yield curve and credit quality universe. The firm manages a variety of products designed to meet various customer risk/return parameters. GEAM's fixed-income team follows a relative value approach, emphasizing a fundamental, bottom-up process with the objective of enhancing returns while limiting volatility. The firm's International Private Equity team invests in companies domiciled and doing a substantial portion of their business outside of the US. They focus primarily on corporate buyouts and growth-equity investments, but they also selectively consider later-stage venture capital investments. GEAM considers investment opportunities across a broad range of industrial sectors and geographic areas and pursues potential investment opportunities in both developed and emerging markets.	Finance
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Miles Laboratories, Inc. Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Stichting Access To Medicine Foundation Stichting Access To Medicine Foundation Miscellaneous Commercial ServicesCommercial Services Engages in stimulating and guiding pharmaceutical companies to do more for the people living in low- and middle-income countries without access to medicine	Commercial Services